Epigenetics of chronic inflammatory diseases by Stylianou E

Get full text

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges by Stylianou, E, Paul, MJ, Reljic, R, McShane, H

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity by Poyntz, H, Betts, G, Stylianou, E, Griffiths, K, Mcshane, H

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection by Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge by Griffiths, K, Stylianou, E, Poyntz, H, Betts, G, Fletcher, H, Mcshane, H

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. by Poyntz, H, Stylianou, E, Griffiths, K, Marsay, L, Checkley, A, Mcshane, H

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice by Griffiths, K, Stylianou, E, Poyntz, H, Betts, G, Fletcher, H, McShane, H

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge by Stylianou, E, Pinpathomrat, N, Sampson, O, Richard, A, Korompis, M, McShane, H

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model by Pinpathomrat, N, Bull, N, Pasricha, J, Harrington-Kandt, R, McShane, H, Stylianou, E

Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation by Bull, NC, Kaveh, DA, Garcia-Pelayo, MC, Stylianou, E, McShane, H, Hogarth, PJ

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection by Betts, G, Poyntz, H, Stylianou, E, Reyes-Sandoval, A, Cottingham, M, Hill, A, McShane, H

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis by Poyntz, H, Stylianou, E, Griffiths, K, Griffiths, K, Marsay, L, Checkley, A, Checkley, A, McShane, H

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A by Stylianou, E, Griffiths, K, Poyntz, H, Harrington-Kandt, R, Dicks, M, Stockdale, L, Betts, G, McShane, H

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine by Stylianou, E, Harrington-Kandt, R, Beglov, Y, Bull, N, Pinpathomrat, N, Swarbrick, G, Lewinsohn, D, Lewinsohn, D, McShane, H

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). by Marsay, L, Matsumiya, M, Tanner, R, Poyntz, H, Griffiths, K, Stylianou, E, Marsh, P, Williams, A, Sharpe, S, Fletcher, H, Mcshane, H

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells by Bull, N, Stylianou, E, Kaveh, D, Pinpathomrat, N, Pasricha, J, Harrington-Kandt, R, Garcia-Pelayo, M, Hogarth, P, McShane, H

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA) by Tanner, R, Zelmer, A, Painter, H, Stylianou, E, Pinpathomrat, N, Harrington-Kandt, R, Biffar, L, Brennan, MJ, McShane, H, Fletcher, HA

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb) by Marsay, L, Matsumiya, M, Tanner, R, Poyntz, H, Griffiths, K, Stylianou, E, Marsh, P, Williams, A, Sharpe, S, Fletcher, H, McShane, H

Enhancing the biological relevance of machine learning classifiers for reverse vaccinology by Heinson, A, Gunawardana, Y, Moesker, B, Hume, C, Vataga, E, Hall, Y, Stylianou, E, McShane, H, Williams, A, Niranjan, M, Woelk, C

Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A by Matsumiya, M, Stylianou, E, Griffiths, K, Lang, Z, Meyer, J, Harris, SA, Rowland, R, Minassian, A, Pathan, A, Fletcher, H, McShane, H